DOCSLIB.ORG

Oxytocin Effects in Mothers and Infants During Breastfeeding

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Oxytocin Effects in Mothers and Infants During Breastfeeding © 2013 SNL All rights reserved REVIEW Oxytocin effects in mothers and infants during breastfeeding Oxytocin integrates the function of several body systems and exerts many effects in mothers and infants during breastfeeding. This article explains the pathways of oxytocin release and reviews how oxytocin can affect behaviour due to its parallel release into the blood circulation and the brain. Oxytocin levels are higher in the infant than in the mother and these levels are affected by mode of birth. The importance of skin-to-skin contact and its association with breastfeeding and mother-infant bonding is discussed. Kerstin Uvnäs Moberg Oxytocin – a system activator increased function of inhibitory alpha-2 3 MD, PhD xytocin, a small peptide of just nine adrenoceptors . Professor of Physiology amino acids, is normally associated The regulation of the release of oxytocin Swedish University of Agriculture O with labour and the milk ejection reflex. is complex and can be affected by different [email protected] However, oxytocin is not only a hormone types of sensory inputs, by hormones such Danielle K. Prime but also a neurotransmitter and a as oestrogen and even by the oxytocin 1,2 molecule itself. This article will focus on PhD paracrine substance in the brain . During Breastfeeding Research Associate breastfeeding it is released into the brain of four major sensory input nervous Medela AG, Baar, Switzerland both mother and infant where it induces a pathways (FIGURES 2 and 3) activated by: great variety of functional responses. 1. Sucking of the mother’s nipple, in which Through three different release pathways the sensory nerves originate in the (FIGURE 1), oxytocin functions rather like a breast. system activator and often influences the 2. Sucking in the infant, in which the release of other signalling substances such sensory nerves originate in the infant as opioids, serotonin, dopamine and oral mucosa. noradrenaline. Through these activations, 3. The presence of food in the different behavioural and physiological gastrointestinal tract, affecting vagal effects are facilitated and coordinated into sensory nerves. adaptive patterns, which are influenced by 4. Skin-to-skin contact in both mothers the type of stimuli and environmental and infants, in which the sensory nerves 3 Keywords factors . that originate in the skin respond to Through the endogenous release of oxytocin; breastfeeding; skin-to-skin; warmth, touch, stroking and light anti-stress; milk ejection; bonding oxytocin or its administration, for example pressure. by nasal spray in humans, various types of Key points socially interactive behaviours can be The mother stimulated. These include maternal and Uvnäs Moberg K., Prime D.K. Oxytocin Milk ejection effects in mothers and infants during sexual behaviours as well as the develop- 4 Oxytocin is critical for milk removal in, breastfeeding. Infant 2013; 9(6): 201-06. ment of bonding and attachment . 1. Oxytocin is released in the mother and Oxytocin stimulates well-being, it induces perhaps, its most renowned role: the milk infant during breastfeeding and skin-to- anti-stress effects, decreases sensitivity to ejection reflex. Following sucking, the skin contact. pain, decreases inflammation and release of oxytocin causes the contraction 2. Milk ejection patterns vary between stimulates processes related to growth and of myoepithelial cells in the breast pushing women. healing. In addition, repeated exposure to milk from the alveoli, through the milk 3. Oxytocin is released into circulating oxytocin may give rise to long-term effects ducts and toward the nipple. blood and brain structures, in parallel. by influencing the production or function In general, it takes around a minute of 4. Oxytocin levels are higher in the infant of other signalling systems. For example, infant sucking or stimulation with a breast than in the mother and differ with noradrenergic activity in the brain pump before milk ejection occurs5,6. mode of birth. may decrease as a consequence of the Interestingly, the milk ejection reflex can be infant VOLUME 9 ISSUE 6 2013 201 REVIEW have continuous milk ejections throughout the milk removal session. Both of these Parvocellular neurons Central oxytocin release: patterns can remove similar volumes of Axons project into brain Magnocellular neurons milk successfully, but the second scenario structures and spinal cord Central oxytocin release: Dendritic extracellular diffusion would require more time to reach that 5 Axons of same level of milk removal . Similar parvocellular neurons repeatability has been observed in Paraventricular individual infants at successive breast- nucleus (PVN) feeds14; these mother-derived patterns may explain why some infants are quick feeders Supraoptic nucleus (SON) and others take a bit more time. Axons of magnocellular Oxytocin-induced effects in the brain neurons It is not known why mothers have such varied milk ejection patterns but, since Anterior pituitary Oxytocin oxytocin is involved in so many functions, these release patterns may not only impact Capillary on milk removal. Systemic oxytocin release and its release into the brain may result in many other outcomes involving Peripheral oxytocin release: breastfeeding and mother-infant Axonal release into blood to target distant organs interactions. For example, breastfeeding in Posterior pituitary mothers is associated with physiological and psychological adaptations including: ■ Increased social interaction FIGURE 1 The release of oxytocin from the supraoptic (SON) and paraventricular (PVN) nuclei ■ Decreased anxiety of the hypothalamus. Magnocellular neurons in the SON and PVN release oxytocin centrally ■ and peripherally from the posterior pituitary, resulting in effects that include milk ejection and Decreased cortisol levels ■ uterine contraction. Parvocellular neurons, located in the PVN, project axons directly into brain Decreased blood pressure structures involved in the regulation of social interaction, anxiety, the activity of the ■ Increased gastrointestinal tract 15-17 hypothalamic-pituitary-adrenal axis, well-being and the autonomic nervous system (eg the function . amygdala, hypothalamus, anterior pituitary, nucleus accumbens, nucleus tractus solitarius and These effects are exerted in the brain but the dorsal vagal motor nucleus). are associated with circulating oxytocin levels, supporting the concept that oxytocin is released systemically and into easily conditioned and many women can birth, but there is still a strong correlation the brain in parallel, as has previously been experience spontaneous milk ejections between the amount of oxytocin released demonstrated in sheep in response to between feeds7,8 as the sight, thought, on the two occasions within individual suckling18. sound and smell of the infant (or even a women13. breast pump in pump-dependent mothers) One pulse of oxytocin is generally The infant can cause milk ejection and dripping of associated with one milk ejection and there Infants produce oxytocin too and in fact, milk from the nipples. Indeed, it is is a relationship between the amount of the production of oxytocin begins in the common that milk ejection occurs prior to oxytocin released and the number of fetus. An understanding of the infant the physical attachment of the infant or a oxytocin pulses during the first 10 minutes oxytocin system is complicated by breast pump7,9. of breastfeeding12. The number of milk difficulties in collecting repeat blood Milk ejection can be associated with ejections during breastfeeding ranges from samples and measuring circulating different sensations that vary dramatically one to 17 over a period of up to 25 oxytocin levels in the newborn. between women. These may be localised to minutes6,7. Similarly, pulsatile patterns of Nevertheless, some studies exist in which the breast such as a ‘drawing’ pain or two to 14 milk ejections are seen during a oxytocin levels have been measured in the tingling, to more systemic sensations such 15 minute breast expression5. The simil- newborn while other studies have as nausea, thirst, fainting or even mental arity between the milk ejection pattern demonstrated the release of oxytocin anxiety and depression8. resulting from breastfeeding and breast indirectly via expression of oxytocin-linked Sucking- and pumping-induced pumping is demonstrated in FIGURE 4. effect patterns. Information can also be oxytocin release has been described as Tracking an individual mother over drawn from animal experiments, as pulsatile7,10. On average, oxytocin pulses time, it appears that her pattern of milk oxytocin exerts similar effect patterns in all occur with 90-second intervals over the ejection repeats throughout the first nine mammals. first 10 minutes of breastfeeding in the first months of lactation5. If a mother has two few days after birth11,12. The amount of or three milk ejections she will continue Infant oxytocin levels are affected by the oxytocin that is released within a 10 that pattern, removing all her milk in these mode of delivery minute breastfeed is much higher at four brief episodes. Other mothers may follow a In infants born by vaginal delivery, months when compared to four days after more constant pulsing profile in that they oxytocin levels in umbilical arterial blood 202 VOLUME 9 ISSUE 6 2013 infant REVIEW were actually higher than in infants born by caesarean section: 69pg/mL Skin-to-skin contact (range 20-315pg/mL) vs 33pg/mL (range 9-195pg/mL), respectively. Mothers also had higher oxytocin
Load more

Recommended publications
  • The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’S Disease
    life Review The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease Gianfranco Natale 1,2,* , Larisa Ryskalin 1 , Gabriele Morucci 1 , Gloria Lazzeri 1, Alessandro Frati 3,4 and Francesco Fornai 1,4 1 Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy; [email protected] (L.R.); [email protected] (G.M.); [email protected] (G.L.); [email protected] (F.F.) 2 Museum of Human Anatomy “Filippo Civinini”, University of Pisa, 56126 Pisa, Italy 3 Neurosurgery Division, Human Neurosciences Department, Sapienza University of Rome, 00135 Rome, Italy; [email protected] 4 Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, 86077 Pozzilli, Italy * Correspondence: [email protected] Abstract: The gastrointestinal (GI) tract is provided with a peculiar nervous network, known as the enteric nervous system (ENS), which is dedicated to the fine control of digestive functions. This forms a complex network, which includes several types of neurons, as well as glial cells. Despite extensive studies, a comprehensive classification of these neurons is still lacking. The complexity of ENS is magnified by a multiple control of the central nervous system, and bidirectional communication between various central nervous areas and the gut occurs. This lends substance to the complexity of the microbiota–gut–brain axis, which represents the network governing homeostasis through nervous, endocrine, immune, and metabolic pathways. The present manuscript is dedicated to Citation: Natale, G.; Ryskalin, L.; identifying various neuronal cytotypes belonging to ENS in baseline conditions.
    [Show full text]
  • Oxytocin Is an Anabolic Bone Hormone
    Oxytocin is an anabolic bone hormone Roberto Tammaa,1, Graziana Colaiannia,1, Ling-ling Zhub, Adriana DiBenedettoa, Giovanni Grecoa, Gabriella Montemurroa, Nicola Patanoa, Maurizio Strippolia, Rosaria Vergaria, Lucia Mancinia, Silvia Coluccia, Maria Granoa, Roberta Faccioa, Xuan Liub, Jianhua Lib, Sabah Usmanib, Marilyn Bacharc, Itai Babc, Katsuhiko Nishimorid, Larry J. Younge, Christoph Buettnerb, Jameel Iqbalb, Li Sunb, Mone Zaidib,2, and Alberta Zallonea,2 aDepartment of Human Anatomy and Histology, University of Bari, 70124 Bari, Italy; bThe Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029; cBone Laboratory, The Hebrew University of Jerusalem, Jerusalem 91120, Israel; dGraduate School of Agricultural Science, Tohoku University, Aoba-ku, Sendai, Miyagi 981-8555 Japan; and eCenter for Behavioral Neuroscience, Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30322 Communicated by Maria Iandolo New, Mount Sinai School of Medicine, New York, NY, February 19, 2009 (received for review October 24, 2008) We report that oxytocin (OT), a primitive neurohypophyseal hor- null mice (5). But the mice are not rendered diabetic, and serum mone, hitherto thought solely to modulate lactation and social glucose homeostasis remains unaltered (9). Thus, whereas the bonding, is a direct regulator of bone mass. Deletion of OT or the effects of OT on lactation and parturition are hormonal, actions OT receptor (Oxtr) in male or female mice causes osteoporosis that mediate appetite and social bonding are exerted centrally. resulting from reduced bone formation. Consistent with low bone The precise neural networks underlying OT’s central effects formation, OT stimulates the differentiation of osteoblasts to a remain unclear; nonetheless, one component of this network mineralizing phenotype by causing the up-regulation of BMP-2, might be the interactions between leptin- and OT-ergic neurones which in turn controls Schnurri-2 and 3, Osterix, and ATF-4 expres- in the hypothalamus (10).
    [Show full text]
  • Neurotransmitter Actions
    Central University of South Bihar Panchanpur, Gaya, India E-Learning Resources Department of Biotechnology NB: These materials are taken/borrowed/modified/compiled from various resources like research articles and freely available internet websites, and are meant to be used solely for the teaching purpose in a public university, and for serving the needs of specified educational programmes. Dr. Jawaid Ahsan Assistant Professor Department of Biotechnology Central University of South Bihar (CUSB) Course Code: MSBTN2003E04 Course Name: Neuroscience Neurotransmitter Actions • Excitatory Action: – A neurotransmitter that puts a neuron closer to an action potential (facilitation) or causes an action potential • Inhibitory Action: – A neurotransmitter that moves a neuron further away from an action potential • Response of neuron: – Responds according to the sum of all the neurotransmitters received at one time Neurotransmitters • Acetylcholine • Monoamines – modified amino acids • Amino acids • Neuropeptides- short chains of amino acids • Depression: – Caused by the imbalances of neurotransmitters • Many drugs imitate neurotransmitters – Ex: Prozac, zoloft, alcohol, drugs, tobacco Release of Neurotransmitters • When an action potential reaches the end of an axon, Ca+ channels in the neuron open • Causes Ca+ to rush in – Cause the synaptic vesicles to fuse with the cell membrane – Release the neurotransmitters into the synaptic cleft • After binding, neurotransmitters will either: – Be destroyed in the synaptic cleft OR – Taken back in to surrounding neurons (reuptake) Excitable cells: Definition: Refers to the ability of some cells to be electrically excited resulting in the generation of action potentials. Neurons, muscle cells (skeletal, cardiac, and smooth), and some endocrine cells (e.g., insulin- releasing pancreatic β cells) are excitable cells.
    [Show full text]
  • Physiology of Hypothalamus and Pituitary
    Physiology of Hypothalamus and Pituitary Simge Aykan, PhD Department of Physiology Ankara University School of Medicine Pituitary Gland • Pituitary gland (hypophysis) is two different tissue types that merged during embryonic development • Anterior pituitary (adenohypophysis): true endocrine gland of epithelial origin • Posterior pituitary (neurohypophysis): extension of the neural tissue of the brain • secretes neurohormones made in the hypothalamus Pituitary Gland • Pituitary bridges and integrates the neural and endocrine mechanisms of homeostasis. • Highly vascular • Posterior pituitary receives arterial blood • anterior pituitary receives only portal venous inflow from the median eminence. • Portal system is particularly important in its function of carrying neuropeptides from the hypothalamus and pituitary stalk to the anterior pituitary. Posterior Pituitary • Storage and release site for two neurohormones (peptide hormones) • Oxytocin • Vasopressin (antidiuretic hormone; ADH) • Large diameter neurons producing hormones are clustered in hypothalamus at paraventricular (oxytocin) and supraoptic nuclei (ADH) • Secretory vesicles containing neurohormones transported to posterior pituitary through axons of the neurons • Stored at the axons until a release signal arrives • Depolarization of the axon terminal opens voltage gated Ca2+ channels and exocytosis is triggered • Hormones release to the circulation Posterior Pituitary • The posterior pituitary regulates water balance and uterine contraction • Vasopressin (ADH), is a neuropeptide
    [Show full text]
  • Oxytocinergic-System-A-Proposal.Pdf
    Opinion Article iMedPub Journals ACTA PSYCHOPATHOLOGICA 2018 www.imedpub.com ISSN 2469-6676 Vol.4 No.3:14 DOI: 10.4172/2469-6676.100170 Oxytocinergic System: A Proposal João Paulo Correia Lima* and Avelino Luiz Rodrigues Received: April 17, 2018; Accepted: May 07, 2018; Published: May 18, 2018 Department of Clinical Psychology and Nucleus of Neuroscience and Behavior, Institute of Psychology, University of Sao Introduction Paulo, Brazil Since 1910, when Ott and Scott [1] published their discovers about the oxytocin participation in milk ejection, the comprehension *Corresponding author: about function and role of oxytocin in several physiological João Paulo Correia Lima functions didn’t stop enlarging and growing. In birth, through his action over uterus contractions, in uterus contractions in [email protected] women’s orgasm and men’s erection [2,3], for instance. However, this approach always considers its peripheral effects. After this, Psychologist for Neuroscience and Behavior, some oxytocin effects had been reported to have actions over Institute of Psychology, University of Sao behavioural traits, like we can see in publishings of Pedersen and Paulo, Brazil. Prange [4] and Winslow and co-workers [5], reporting the oxytocin actions over, respectively, maternal behaviour and pair bonding. Tel: +55-11-32852420; +55-11-983439754 Since then, the increasing data about the oxytocin’s function in behaviour and its central action can’t be ignored. In this short proposal, we’ll consider the opportunity or utility of thinking Citation about oxytocin as a system, instead of a single neurotransmitter. : Lima JPC, Rodrigues AL (2018) Oxytocinergic System: A Proposal. Acta Neurotransmitter or Hormone: Central Psychopathol Vol.4 No.3:14 and Peripheral Actions of Oxytocin Once a molecule could have his function defined through the way death, passive avoidance).
    [Show full text]
  • Transition from Biological to Chemical Assay for Quality Assurance of Medicinal Substances (Apis) and Formulated Preparations
    WHO/BS/07.2070 ENGLISH ONLY EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva - 8 to 12 October 2007 Discussion paper: Transition from biological to chemical assay for quality assurance of medicinal substances (APIs) and formulated preparations A Bristow National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Herts EN6 3QG, UK ML Rabouhans, J Joung, DJ Wood World Health Organization, Geneva, Switzerland © World Health Organization 2007 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected] ). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected] ). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
    [Show full text]
  • Oxytocin to Accelerate Or Induce Labour
    CLINICAL PRACTICE GUIDELINE OXYTOCIN CLINICAL PRACTICE GUIDELINE OXYTOCIN TO ACCELERATE OR INDUCE LABOUR Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and the Clinical Strategy and Programmes Division, Health Service Executive Version: 1.0 Publication date: April 2016 Guideline No: 36 Revision date: April 2019 CLINICAL PRACTICE GUIDELINE OXYTOCIN Table of Contents 1. Revision History ....................................................................................................................... 3 2. Key recommendations .......................................................................................................... 3 3. Purpose and Scope ................................................................................................................. 4 4. Background ............................................................................................................................... 5 5. Methodology .............................................................................................................................. 9 6. Clinical guideline ................................................................................................................... 10 7. References .............................................................................................................................. 16 8. Implementation Strategy ................................................................................................... 19 9. Key Performance Indicators ............................................................................................
    [Show full text]
  • Understanding Peptide Binding in Class a G Protein-Coupled Receptors
    Molecular Pharmacology Fast Forward. Published on July 10, 2019 as DOI: 10.1124/mol.119.115915 This article has not been copyedited and formatted. The final version may differ from this version. MOL# 115915 Understanding peptide binding in Class A G protein-coupled receptors Irina G. Tikhonova, Veronique Gigoux, Daniel Fourmy School of Pharmacy, Medical Biology Centre, Queen’s University Belfast, Belfast BT9 7BL, Northern Ireland, United Kingdom, (I.G.T.) INSERM ERL1226-Receptology and Therapeutic Targeting of Cancers, Laboratoire de Physique et Chimie des Nano-Objets, CNRS UMR5215-INSA, Université de Toulouse III, F- 31432 Toulouse, France. (V.G., D.F.) Downloaded from molpharm.aspetjournals.org Keywords: peptides, peptide GPCRs, peptide binding at ASPET Journals on September 30, 2021 1 Molecular Pharmacology Fast Forward. Published on July 10, 2019 as DOI: 10.1124/mol.119.115915 This article has not been copyedited and formatted. The final version may differ from this version. MOL# 115915 Running title page: Peptide Class A GPCRs Corresponding author: Irina G. Tikhonova School of Pharmacy, Medical Biology Centre, 97 Lisburn Road, Queen’s University Belfast, Belfast BT9 7BL, Northern Ireland, United Kingdom Email: [email protected] Tel: +44 (0)28 9097 2202 Downloaded from Number of text pages: 10 Number of figures: 3 molpharm.aspetjournals.org Number of references: 118 Number of tables: 2 Words in Abstract: 163 Words in Introduction: 503 Words in Concluding Remarks: 661 at ASPET Journals on September 30, 2021 ABBREVIATIONS: AT1,
    [Show full text]
  • Neuroscience: the Science of the Brain
    NEUROSCIENCE SCIENCE OF THE BRAIN AN INTRODUCTION FOR YOUNG STUDENTS British Neuroscience Association European Dana Alliance for the Brain Neuroscience: the Science of the Brain 1 The Nervous System P2 2 Neurons and the Action Potential P4 3 Chemical Messengers P7 4 Drugs and the Brain P9 5 Touch and Pain P11 6 Vision P14 Inside our heads, weighing about 1.5 kg, is an astonishing living organ consisting of 7 Movement P19 billions of tiny cells. It enables us to sense the world around us, to think and to talk. The human brain is the most complex organ of the body, and arguably the most 8 The Developing P22 complex thing on earth. This booklet is an introduction for young students. Nervous System In this booklet, we describe what we know about how the brain works and how much 9 Dyslexia P25 there still is to learn. Its study involves scientists and medical doctors from many disciplines, ranging from molecular biology through to experimental psychology, as well as the disciplines of anatomy, physiology and pharmacology. Their shared 10 Plasticity P27 interest has led to a new discipline called neuroscience - the science of the brain. 11 Learning and Memory P30 The brain described in our booklet can do a lot but not everything. It has nerve cells - its building blocks - and these are connected together in networks. These 12 Stress P35 networks are in a constant state of electrical and chemical activity. The brain we describe can see and feel. It can sense pain and its chemical tricks help control the uncomfortable effects of pain.
    [Show full text]
  • Mechanism for Neurotransmitter-Receptor Matching
    Mechanism for neurotransmitter-receptor matching Dena R. Hammond-Weinbergera,1,2, Yunxin Wanga, Alex Glavis-Blooma, and Nicholas C. Spitzera,b,1 aNeurobiology Section, Division of Biological Sciences, University of California San Diego, La Jolla, CA 92093-0357; and bCenter for Neural Circuits and Behavior, Kavli Institute for Brain and Mind, University of California San Diego, La Jolla, CA 92161 Contributed by Nicholas C. Spitzer, January 6, 2020 (sent for review September 25, 2019; reviewed by Laura N. Borodinsky and Joshua R. Sanes) Synaptic communication requires the expression of functional neurons lead to the appearance of functional neuromuscular postsynaptic receptors that match the presynaptically released junctions expressing GluR1 and GluR2 (alias GluA1 and GluA2) neurotransmitter. The ability of neurons to switch the transmitter subunits, which are blocked by the AMPA receptor antagonist they release is increasingly well documented, and these switches GYKI 52466 (16, 17). In the central nervous system, the natural require changes in the postsynaptic receptor population. Al- developmental transmitter switch from GABA to glycine in the though the activity-dependent molecular mechanism of neuro- auditory nervous system is accompanied by alterations in the transmitter switching is increasingly well understood, the basis properties of postsynaptic receptors (18, 19). Changes in illumi- of specification of postsynaptic neurotransmitter receptors match- nation during development or in photoperiod in the adult lead to ing the newly expressed transmitter is unknown. Using a func- changes in the numbers of neurons expressing dopamine in the tional assay, we show that sustained application of glutamate to embryonic vertebrate skeletal muscle cells cultured before hypothalamus that are accompanied by corresponding up- or innervation is necessary and sufficient to up-regulate ionotropic down-regulation of dopamine receptor expression in postsynaptic glutamate receptors from a pool of different receptors expressed neurons (5, 7).
    [Show full text]
  • Neurotransmitter Notes
    Synapses and Neurotransmitters Notes Chemical Transmitters called “Neurotransmitters” carry a signal across Synapses (& at Neuromuscular Junctions) A point of contact between two neurons is called a synapse At the synapse there is a break in electrical transmission (the action potential cannot cross). Instead chemicals called “neurotransmitters” are released that carry the signal to the next nerve. There is a delay at synapses, because chemical transmission between neurons is slower than electrical transmission (action potential) within a neuron. A neuromuscular junction (NMJ) is a contact between a neuron and a muscle: it is like a synapse in that the action potential stops and the signal is carried by a chemical neurotransmitter released by the neuron. Neurotransmitters Are Made and Stored in the Pre-synaptic Terminal The end of the neuron enlarges into an axon terminal Neurotransmitters are produced in the cell body of a neuron and then transported to the ends of the axon terminals in small membrane-enclosed sacs called “synaptic vesicles”. At the axon terminus, neurotransmitters are stored in these tiny synaptic vesicles so that they can be released when an action potential reaches the axon terminus At a synapse, axon termini of the pre-synaptic neuron contact the dendrites of the post-synaptic neuron. Because the neurotransmitter is only located in the axon termini on one side of a synapse, the impulse can go in only one direction. Calcium is Required for Neurotransmitter Release Neurotransmitter release requires Ca2+ ions Normally, the concentration of Ca2+ in the pre-synaptic neuron l is kept very low (by the action of a Ca pump).
    [Show full text]
  • 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice
    Neuropsychopharmacology (2017) 42, 2163–2177 © 2017 American College of Neuropsychopharmacology. All rights reserved 0893-133X/17 www.neuropsychopharmacology.org 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice 1 1,2 3,7 4 1 Vladimir M Pogorelov , Ramona M Rodriguiz , Jianjun Cheng , Mei Huang , Claire M Schmerberg , 4 5 3 ,1,2,6 Herbert Y Meltzer , Bryan L Roth , Alan P Kozikowski and William C Wetsel* 1 2 Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Mouse Behavioral and Neuroendocrine 3 Analysis Core Facility, Duke University Medical Center, Durham, NC, USA; Drug Discovery Program, Department of Medicinal Chemistry and 4 Pharmacognosy, College of Pharmacy, University of Illinois, Chicago, IL, USA; Department of Psychiatry and Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; 5National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, 6 USA; Departments of Cell Biology and Neurobiology, Duke University Medical Center, Durham, NC, USA All FDA-approved antipsychotic drugs (APDs) target primarily dopamine D2 or serotonin (5-HT2A) receptors, or both; however, these medications are not universally effective, they may produce undesirable side effects, and provide only partial amelioration of negative and cognitive symptoms. The heterogeneity of pharmacological responses in schizophrenic patients suggests that additional drug targets may be effective in improving aspects of this syndrome. Recent evidence suggests that 5-HT receptors may be a promising target for 2C schizophrenia since their activation reduces mesolimbic nigrostriatal dopamine release (which conveys antipsychotic action), they are expressed almost exclusively in CNS, and have weight-loss-promoting capabilities.
    [Show full text]